Genoa Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Series A
Geographical Focus
United States
Industries Focus
- Agriculture
- Diagnostics
- Biotechnology
- Synthetic Biology
- Research Tools
- Animal Health
- Industrial Bio
- Genetic Engineering
- Drug Development
- Bio Manufacturing
- Biodefense
Investor Details Founded: 2018
Genoa Ventures is a venture capital firm investing in early-stage companies at the intersection of biology and technology. The firm focuses on sectors such as biotechnology, agriculture, diagnostics, synthetic biology, industrial bio, and genetic engineering. Their investment strategy emphasizes identifying and nurturing innovative life science technologies with the potential to transform industries and address fundamental challenges to life. Genoa Ventures provides strategic guidance and staged investing to ensure institutional best practices during the earliest stages of a company’s journey, promoting portfolio diversity and fund sizes that align with top-tier venture capital returns. The firm has a track record of successful investments, including the acquisition of Intabio by SCIEX in 2021. Genoa Ventures is headquartered in San Francisco, California, and can be contacted via email at info@genoavc.com or by phone at +1 (415) 869-8848. For more information, visit their official website at https://www.genoavc.com/.
Requirements
- Innovative life science technologies
- Early-stage companies
- Potential to transform industries
- Address fundamental challenges to life
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Aqtual
- Stemson
- Epitel
- SimBioSys
- Meiogenix
- Redux
- Codetta
Mentioned In
-
$24.95
-
$49.95
-
$14.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of Genoa Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim